Below is a list of items that CPSU has found problematic to source:
|
G014
|
FRAMYCETIN, GRAMICIDIN,
DEXAMETHASONE EYE DROPS
|
|
G023
|
PILOCARPINE
HYDROCHLORIDE 1%
|
|
J205
|
Sodium stibogluconate
injections
|
|
J210
|
Spectinomycin 2g
injections
|
|
J355
|
CEFTRIAXONE 500MG INJ
|
|
RV003
|
Diazepam 10mg emulsion
injection - Diazemuls®
|
Disclaimer: List problematic to source 4th January 2021. This list will be updated regularly and is dynamic. Anyone
interested to supply or recommend an alternative is invited to address CPSU MFH
on info.cpsu@gov.mt subject title:
Problematic to Source and for quantities one should refer to the consumption
within the same website - CPSU as a rule of thumb will accept to procure up to
6 months top-up to current available stock, unless there are further
directions. The responsible person will send the bid received for
evaluation and if technically compliant an order will be raised within 24-48
hours. The procurement process will be considered to be as a Direct order
due to the urgent issue related to access of treatment. In case that more
than one bidder approaches the contracting authority during the same time the
process will tackle delivery as an arbitrary decision. The item will be
removed from the list once the stock is delivered within CPSU.
Further information regarding the above items problematic to source please contact us on info.cpsu@gov.mt or at our offices Central Procurement & Supplies Unit, UB002 Industrial Estate San Gwann, SGN3000
on any working day between 8.30am and 12.00pm